beta-thujaplicinol has been researched along with raltegravir in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, X; Daelemans, D; De Clercq, E; Ding, X; Dong, G; Gao, P; Liu, X; Menéndez-Arias, L; Pannecouque, C; Sun, L; Wang, X; Zhan, P; Zhang, X | 1 |
| Álvarez, M; Cheng, X; De Clercq, E; Gao, P; Liu, X; Luczkowiak, J; Menéndez-Arias, L; Pannecouque, C; Song, S; Sun, L; Zhan, P | 1 |
| Amendola, G; Andreola, ML; Corona, A; Cosconati, S; Costi, R; De Leo, A; De Vita, D; Di Santo, R; Esposito, F; Grandi, N; Ialongo, D; Madia, VN; Messore, A; Métifiot, M; Novellino, E; Saccoliti, F; Scipione, L; Tramontano, E; Tudino, V | 1 |
3 other study(ies) available for beta-thujaplicinol and raltegravir
| Article | Year |
|---|---|
5-Hydroxypyrido[2,3-b]pyrazin-6(5H)-one derivatives as novel dual inhibitors of HIV-1 reverse transcriptase-associated ribonuclease H and integrase.
Topics: Anti-HIV Agents; Dose-Response Relationship, Drug; HIV; HIV Integrase; HIV Integrase Inhibitors; Microbial Sensitivity Tests; Molecular Structure; Pyrazines; Reverse Transcriptase Inhibitors; Ribonuclease H; Structure-Activity Relationship | 2018 |
Design, synthesis and biological evaluation of 3-hydroxyquinazoline-2,4(1H,3H)-diones as dual inhibitors of HIV-1 reverse transcriptase-associated RNase H and integrase.
Topics: Anti-HIV Agents; Caco-2 Cells; Cell Line; Cell Membrane Permeability; Dose-Response Relationship, Drug; Drug Design; Enzyme Inhibitors; HIV Integrase; HIV Reverse Transcriptase; HIV-1; HIV-2; Humans; Models, Molecular; Molecular Structure; Quinazolinones; Ribonuclease H, Human Immunodeficiency Virus; Structure-Activity Relationship | 2019 |
Quinolinonyl Non-Diketo Acid Derivatives as Inhibitors of HIV-1 Ribonuclease H and Polymerase Functions of Reverse Transcriptase.
Topics: Anti-HIV Agents; HeLa Cells; HIV-1; Humans; Magnesium; Microbial Sensitivity Tests; Molecular Docking Simulation; Mutagenesis, Site-Directed; Mutation; Protein Binding; Quinolones; Reverse Transcriptase Inhibitors; Ribonuclease H, Human Immunodeficiency Virus; Virus Replication | 2021 |